Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
Enzymes of amide and ureide biogenesis in developing soybean nodules.

Plant physiology

Reynolds PH, Boland MJ, Blevins DG, Schubert KR, Randall DD.
PMID: 16662397
Plant Physiol. 1982 Jun;69(6):1334-8. doi: 10.1104/pp.69.6.1334.

Amide and ureide biogenic enzymes were measured in the plant fraction of soybean (Glycine max) nodules during the period 11 to 23 days after inoculation with Rhizobium japonicum (USDA 3I1b142). Enzymes involved in the initial assimilation of ammonia, i.e....

Cite
Reynolds PH, Boland MJ, Blevins DG, et al. Enzymes of amide and ureide biogenesis in developing soybean nodules. Plant Physiol. 1982;69(6):1334-8doi: 10.1104/pp.69.6.1334.
Reynolds, P. H., Boland, M. J., Blevins, D. G., Schubert, K. R., & Randall, D. D. (1982). Enzymes of amide and ureide biogenesis in developing soybean nodules. Plant physiology, 69(6), 1334-8. https://doi.org/10.1104/pp.69.6.1334
Reynolds, P H, et al. "Enzymes of amide and ureide biogenesis in developing soybean nodules." Plant physiology vol. 69,6 (1982): 1334-8. doi: https://doi.org/10.1104/pp.69.6.1334
Reynolds PH, Boland MJ, Blevins DG, Schubert KR, Randall DD. Enzymes of amide and ureide biogenesis in developing soybean nodules. Plant Physiol. 1982 Jun;69(6):1334-8. doi: 10.1104/pp.69.6.1334. PMID: 16662397; PMCID: PMC426412.
Copy Download .nbib Format: NLM
Subcellular organization of ureide biogenesis from glycolytic intermediates and ammonium in nitrogen-fixing soybean nodules.

Planta

Boland MJ, Hanks JF, Reynolds PH, Blevins DG, Tolbert NE, Schubert KR.
PMID: 24271625
Planta. 1982 Jun;155(1):45-51. doi: 10.1007/BF00402930.

Subcellular organelle fractionation of nitrogen-fixing nodules of soybean (Glycine max (L.) Merr.) indicates that a number of enzymes involved in the assimilation of ammonia into amino acids and purines are located in the proplastids. These include asparagine synthetase (EC...

Cite
Boland MJ, Hanks JF, Reynolds PH, et al. Subcellular organization of ureide biogenesis from glycolytic intermediates and ammonium in nitrogen-fixing soybean nodules. Planta. 1982;155(1):45-51doi: 10.1007/BF00402930.
Boland, M. J., Hanks, J. F., Reynolds, P. H., Blevins, D. G., Tolbert, N. E., & Schubert, K. R. (1982). Subcellular organization of ureide biogenesis from glycolytic intermediates and ammonium in nitrogen-fixing soybean nodules. Planta, 155(1), 45-51. https://doi.org/10.1007/BF00402930
Boland, M J, et al. "Subcellular organization of ureide biogenesis from glycolytic intermediates and ammonium in nitrogen-fixing soybean nodules." Planta vol. 155,1 (1982): 45-51. doi: https://doi.org/10.1007/BF00402930
Boland MJ, Hanks JF, Reynolds PH, Blevins DG, Tolbert NE, Schubert KR. Subcellular organization of ureide biogenesis from glycolytic intermediates and ammonium in nitrogen-fixing soybean nodules. Planta. 1982 Jun;155(1):45-51. doi: 10.1007/BF00402930. PMID: 24271625.
Copy Download .nbib Format: NLM
Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer.

Molecular cancer therapeutics

Dekhne AS, Hou Z, Gangjee A, Matherly LH.
PMID: 32879053
Mol Cancer Ther. 2020 Nov;19(11):2245-2255. doi: 10.1158/1535-7163.MCT-20-0423. Epub 2020 Sep 02.

One-carbon (1C) metabolism encompasses folate-mediated 1C transfer reactions and related processes, including nucleotide and amino acid biosynthesis, antioxidant regeneration, and epigenetic regulation. 1C pathways are compartmentalized in the cytosol, mitochondria, and nucleus. 1C metabolism in the cytosol has been...

Cite
Dekhne AS, Hou Z, Gangjee A, et al. Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer. Mol Cancer Ther. 2020;19(11):2245-2255doi: 10.1158/1535-7163.MCT-20-0423.
Dekhne, A. S., Hou, Z., Gangjee, A., & Matherly, L. H. (2020). Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer. Molecular cancer therapeutics, 19(11), 2245-2255. https://doi.org/10.1158/1535-7163.MCT-20-0423
Dekhne, Aamod S, et al. "Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer." Molecular cancer therapeutics vol. 19,11 (2020): 2245-2255. doi: https://doi.org/10.1158/1535-7163.MCT-20-0423
Dekhne AS, Hou Z, Gangjee A, Matherly LH. Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer. Mol Cancer Ther. 2020 Nov;19(11):2245-2255. doi: 10.1158/1535-7163.MCT-20-0423. Epub 2020 Sep 02. PMID: 32879053; PMCID: PMC7921203.
Copy Download .nbib Format: NLM
Monitoring forced degradation of drugs using silica coated AgNPs with surface-enhanced Raman scattering.

Talanta

Yilmaz H, Cobandede Z, Yilmaz D, Cinkilic A, Culha M, Demiralay EC.
PMID: 32278418
Talanta. 2020 Jul 01;214:120828. doi: 10.1016/j.talanta.2020.120828. Epub 2020 Feb 12.

Potential degradation products (DPs), even in small concentrations, can cause changes in pharmacological and toxicological properties of a drug with a significant impact on product quality and safety. Thus, their stability and understanding of possible degradation mechanisms have a...

Cite
Yilmaz H, Cobandede Z, Yilmaz D, et al. Monitoring forced degradation of drugs using silica coated AgNPs with surface-enhanced Raman scattering. Talanta. 2020;214:120828doi: 10.1016/j.talanta.2020.120828.
Yilmaz, H., Cobandede, Z., Yilmaz, D., Cinkilic, A., Culha, M., & Demiralay, E. C. (2020). Monitoring forced degradation of drugs using silica coated AgNPs with surface-enhanced Raman scattering. Talanta, 214120828. https://doi.org/10.1016/j.talanta.2020.120828
Yilmaz, Hulya, et al. "Monitoring forced degradation of drugs using silica coated AgNPs with surface-enhanced Raman scattering." Talanta vol. 214 (2020): 120828. doi: https://doi.org/10.1016/j.talanta.2020.120828
Yilmaz H, Cobandede Z, Yilmaz D, Cinkilic A, Culha M, Demiralay EC. Monitoring forced degradation of drugs using silica coated AgNPs with surface-enhanced Raman scattering. Talanta. 2020 Jul 01;214:120828. doi: 10.1016/j.talanta.2020.120828. Epub 2020 Feb 12. PMID: 32278418.
Copy Download .nbib Format: NLM
Influence of reduced folate carrier and dihydrofolate reductase genes on methotrexate-induced cytotoxicity.

Cancer research and treatment

Yoon SA, Choi JR, Kim JO, Shin JY, Zhang X, Kang JH.
PMID: 20948922
Cancer Res Treat. 2010 Sep;42(3):163-71. doi: 10.4143/crt.2010.42.3.163. Epub 2010 Sep 30.

PURPOSE: The aim of this study is to investigate the effect of genetic variations and the expression of the reduced folate carrier (RFC) and dihydrofolate reductase (DHFR) on the drug sensitivity to methotrexate (MTX) in different cancer cell lines.MATERIALS...

Cite
Yoon SA, Choi JR, Kim JO, et al. Influence of reduced folate carrier and dihydrofolate reductase genes on methotrexate-induced cytotoxicity. Cancer Res Treat. 2010;42(3):163-71doi: 10.4143/crt.2010.42.3.163.
Yoon, S. A., Choi, J. R., Kim, J. O., Shin, J. Y., Zhang, X., & Kang, J. H. (2010). Influence of reduced folate carrier and dihydrofolate reductase genes on methotrexate-induced cytotoxicity. Cancer research and treatment, 42(3), 163-71. https://doi.org/10.4143/crt.2010.42.3.163
Yoon, Seong-Ae, et al. "Influence of reduced folate carrier and dihydrofolate reductase genes on methotrexate-induced cytotoxicity." Cancer research and treatment vol. 42,3 (2010): 163-71. doi: https://doi.org/10.4143/crt.2010.42.3.163
Yoon SA, Choi JR, Kim JO, Shin JY, Zhang X, Kang JH. Influence of reduced folate carrier and dihydrofolate reductase genes on methotrexate-induced cytotoxicity. Cancer Res Treat. 2010 Sep;42(3):163-71. doi: 10.4143/crt.2010.42.3.163. Epub 2010 Sep 30. PMID: 20948922; PMCID: PMC2953780.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries